— Know what they know.
Not Investment Advice
Also trades as: XAGEW (NASDAQ) · $vol 0M

XAGE OTC

Longevity Health Holdings Inc.
1W: -20.9% 1M: -44.6% 3M: -52.5% YTD: -59.0% 1Y: -79.8% 3Y: -99.9% 5Y: -100.0%
$0.12
-0.01 (-10.12%)
 
Weekly Expected Move ±9.7%
$0 $0 $0 $0 $0
OTC · Healthcare · Biotechnology · Tech Score Strong Sell · Power 35 · $176556 mcap · 893389 float · 0.151% daily turnover · Short 30% of daily vol

Balance Sheet Trends

Total Assets
$1M -97.7% ▼
3Y CAGR: -1.8%
Total Liabilities
$6M -84.2% ▼
3Y CAGR: -41.6%
Shareholders Equity
-$5M -119.0% ▼
Cash & Investments
$157K -94.6% ▼
3Y CAGR: -41.2%
Total Debt
$639K -70.1% ▼
3Y CAGR: -59.6%
Net Debt
$482K +162.1% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024
— Assets —
Cash$774K$128K$3M$157K
Short-Term Investments$0$0$0$0
Cash & ST Investments$774K$128K$3M$157K
Net Receivables$0$0$205K$306K
Inventory$0$0$0$109K
Other Current Assets-$794K$422K$59M$86K
Total Current Assets$179K$606K$63M$956K
Property, Plant & Equip.$1M$1M$1M$499K
Goodwill & Intangibles$33K$29K$24K$20K
Long-Term Investments$154M$157M$0$0
Other Non-Current Assets-$154M-$157M$0$0
Total Non-Current Assets$1M$1M$1M$518K
Total Assets$2M$2M$64M$1M
— Liabilities —
Accounts Payable$871K$2M$4M$4M
Short-Term Debt$9M$3M$1M$241K
Deferred Revenue$2M$1M$0$0
Other Current Liabilities$2M$349K$31M$0
Total Current Liabilities$16M$7M$39M$6M
Long-Term Debt$922$0$0$0
Other Non-Current Liab.$14M$31M$0$0
Total Non-Current Liabilities$15M$32M$698K$310K
Total Liabilities$31M$40M$39M$6M
— Equity —
Common Stock$37K$15K$2K$2K
Retained Earnings-$33M-$42M-$59M-$69M
Accumulated OCI$0-$31M$0$0
Total Stockholders Equity-$30M-$38M$25M-$5M
Total Liabilities & Equity$2M$2M$64M$1M
— Key Metrics —
Total Debt$10M$4M$2M$639K
Net Debt$9M$4M-$776K$482K
Total Investments$154M$157M$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms